It has been reported that CD38 is involved in neurodegenerative diseases (Blacher et al., 2015; Meyer et al., 2022); thus, sUA in central nervous system tissues may directly inhibit CD38 activity to limit neuroinflammation and the progression of such diseases. The gene discussed is CD38; the disease is neurodegenerative disease.